Idursulfase
ATC A16AB09 · 8 markets · 9 records
Idursulfase
Forms
AU 2 records · 2 strengths
- 6 mginjectionELAPRASE idursulfase-rhu concentrate for solution for IV infusion vial
Records without a stated strength · 1 ELAPRASE
US 1 records · 1 strengths
- 6 mg/3 mLliquidELAPRASE
GB 1 records · 1 strengths
- 6 mg/3 mLinjectionElaprase 6mg/3ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 2 mgliquidELAPRASE
SG 1 records · 1 strengths
- 6 mg/vialinjectionElaprase (TM) Solution for Intravenous Infusion 2mg/ ml
TW 1 records · 1 strengths
Records without a stated strength · 1 ELAPRASE (idursulfase) Injection、移黏寶酶靜脈輸液
HK 1 records · 1 strengths
Records without a stated strength · 1 ELAPRASE INJ 2MG/ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ELAPRASE
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.